Early phase I clinical trial results for 4-demethyl-4-cholesteryloxycarbonylpenclomedine (DM-CHOC-PEN) plus radiation in cancers involving the CNS Article
Full Text via DOI: 10.1158/1538-7445.AM2018-CT119
Web of Science: 000468818900109